Onderneming Aclaris Therapeutics, Inc.
Aandelen
ACRS
US00461U1051
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,2 USD | +0,84% | -3,23% | +14,29% |
Vakgebied
Aantal werknemers: 89
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutics
90,3
%
| 25 | 85,2 % | 28 | 90,3 % | +11,27% |
Contract Research
9,7
%
| 17 | 57,2 % | 3 | 9,7 % | -82,15% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 30 | 100,0 % | 31 | 100,0 % | +5,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 54 | 01-07-12 |
Kevin Balthaser
DFI | Director of Finance/CFO | - | 01-01-17 |
Ajay Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-21 |
Joseph Monahan
CTO | Chief Tech/Sci/R&D Officer | 68 | - |
General Counsel | - | 01-06-18 | |
James Loerop
PRN | Corporate Officer/Principal | 60 | 31-01-22 |
Elaine Morefield
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 09-08-17 |
Maxine Gowen
BRD | Director/Board Member | 66 | 02-07-19 |
Andrew Powell
BRD | Director/Board Member | 66 | 25-01-17 |
Director/Board Member | 60 | 07-01-20 | |
Director/Board Member | 57 | 01-09-16 | |
Neal Walker
CEO | Chief Executive Officer | 54 | 01-07-12 |
Anand Mehra
BRD | Director/Board Member | 48 | 01-09-14 |
Director/Board Member | 58 | 01-09-14 | |
Bryan Reasons
BRD | Director/Board Member | 56 | 24-04-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 71 264 786 | 69 291 948 ( 97,23 %) | 0 | 97,23 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,29% | 85,52 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers ACRS
- Onderneming Aclaris Therapeutics, Inc.